Detalhe da pesquisa
1.
Efficacy of ruxolitinib in the treatment of relapsed/refractory large granular lymphocytic leukaemia.
Br J Haematol
; 2024 Apr 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-38639192
2.
Prognostic relevance of sarcopenia, geriatric, and nutritional assessments in older patients with diffuse large B-cell lymphoma: results of a multicentric prospective cohort study.
Ann Hematol
; 102(7): 1811-1823, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-37058153
3.
Work and education interruption in long-term Hodgkin lymphoma survivors: an analysis among patients from nine EORTC-LYSA trials.
Acta Oncol
; 62(7): 744-752, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-37039661
4.
High-risk stage IIB Hodgkin lymphoma treated in the H10 and AHL2011 trials: total metabolic tumor volume is a useful risk factor to stratify patients at baseline.
Haematologica
; 107(12): 2897-2904, 2022 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35638548
5.
Red blood cell transfusion burden in myelodysplastic syndromes (MDS) with ring Sideroblasts (RS): A retrospective multicenter study by the Groupe Francophone des Myélodysplasies (GFM).
Transfusion
; 62(5): 961-973, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35452143
6.
Retrospective analysis of the safety of peripherally inserted catheters versus implanted port catheters during first-line treatment for patients with diffuse large B-cell lymphoma.
Eur J Haematol
; 109(1): 41-49, 2022 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-35285085
7.
Targeted genotyping of circulating tumor DNA for classical Hodgkin lymphoma monitoring: a prospective study.
Haematologica
; 106(1): 154-162, 2021 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32079702
8.
Composite and sequential lymphoma between classical Hodgkin lymphoma and primary mediastinal lymphoma/diffuse large B-cell lymphoma, a clinico-pathological series of 25 cases.
Br J Haematol
; 189(2): 244-256, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32030731
9.
PET-adapted treatment for newly diagnosed advanced Hodgkin lymphoma (AHL2011): a randomised, multicentre, non-inferiority, phase 3 study.
Lancet Oncol
; 20(2): 202-215, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30658935
10.
Patient and physician preferences for first-line treatment of classical Hodgkin lymphoma in Germany, France and the United Kingdom.
Br J Haematol
; 184(2): 202-214, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30239982
11.
A phase II study of guadecitabine in higher-risk myelodysplastic syndrome and low blast count acute myeloid leukemia after azacitidine failure.
Haematologica
; 104(8): 1565-1571, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30733271
12.
Correction to: Prognostic relevance of sarcopenia, geriatric, and nutritional assessments in older patients with diffuse large Bcell lymphoma: results of a multicentric prospective cohort study.
Ann Hematol
; 103(1): 369, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37880485
13.
Fatigue level changes with time in long-term Hodgkin and non-Hodgkin lymphoma survivors: a joint EORTC-LYSA cross-sectional study.
Health Qual Life Outcomes
; 17(1): 115, 2019 Jul 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31266501
14.
Acadesine Circumvents Azacitidine Resistance in Myelodysplastic Syndrome and Acute Myeloid Leukemia.
Int J Mol Sci
; 21(1)2019 12 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-31881723
15.
Myelodysplastic syndrome (MDS) with isolated trisomy 8: a type of MDS frequently associated with myeloproliferative features? A report by the Groupe Francophone des Myélodysplasies.
Br J Haematol
; 182(6): 843-850, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30004110
16.
Azacitidine improves outcome in higher-risk MDS patients with chromosome 7 abnormalities: a retrospective comparison of GESMD and GFM registries.
Br J Haematol
; 181(3): 350-359, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29611196
17.
Effect of lenalidomide treatment on clonal architecture of myelodysplastic syndromes without 5q deletion.
Blood
; 127(6): 749-60, 2016 Feb 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-26626993
18.
A phase II study of the oral JAK1/JAK2 inhibitor ruxolitinib in advanced relapsed/refractory Hodgkin lymphoma.
Haematologica
; 103(5): 840-848, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29351986
19.
Can nivolumab alone cure patients with relapse or refractory Hodgkin lymphoma? A 5-year analysis of the French early access program (EPA).
Br J Haematol
; 198(1): 203-206, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35445392
20.
Lenalidomide combined with intensive chemotherapy in acute myeloid leukemia and higher-risk myelodysplastic syndrome with 5q deletion. Results of a phase II study by the Groupe Francophone Des Myélodysplasies.
Haematologica
; 102(4): 728-735, 2017 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28034993